Efficacy of 125I vs non-125I combined with transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma with obstructive jaundice
Digestive Diseases and Sciences Jan 11, 2018
Li S, et al. - Therapeutic effects of 125I vs non-125I combined with transcatheter arterial chemoembolization (TACE) were compared for the treatment of unresectable hepatocellular carcinoma (HCC) with obstructive jaundice. Compared to TACE without the radioactive seeds, the combination of 125I with TACE was found to be more effective for treating patients with unresectable HCC with obstructive jaundice.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
